Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...

A “gold standard” trial found that semaglutide helped reduce drinking in people with obesity who sought out treatment for ...

Semaglutide cut heavy drinking days by about 41%, the study found.

Compared with placebo, semaglutide achieved larger reductions in heavy-drinking days (−41.1 vs −26.4 percentage points) and ...

April 30, 2026 expert reaction to an RCT for semaglutide in patients with alcohol use disorder and comorbid obesity . A randomised controlled trial published in The Lancet looks a ...

A trial of 108 adults with obesity seeking treatment for alcohol use finds a once-weekly semaglutide injection reduced heavy ...

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies. While more research is needed, preclinical and ...

Newleos doses the first participant in a Phase 1b study of NTX-2001, a potential first-in-class TAAR1 partial agonist for ...

Even people who never exceed the recommended limits for alcohol consumption are likely to experience brain health problems as ...

Alcohol affects men and women very differently, especially women dependent on alcohol. For five years, the Yale Program on Sex Differences in Alcohol Use Disorder (AUD), headed by Dr. Sherry McKee, ...

The FBI director has until April 28 to answer 10 questions about his relationship with alcohol.